Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16471237)

  • 1. [The value of integrated PET-CT images in 2 lymphoma patients with skeletal localisations].
    Geerts MC; Quarles van Ufford HM; Kramer MH; van Waes PF; de Klerk JM
    Ned Tijdschr Geneeskd; 2006 Jan; 150(4):204-9. PubMed ID: 16471237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of PET in lymphoma.
    Jhanwar YS; Straus DJ
    J Nucl Med; 2006 Aug; 47(8):1326-34. PubMed ID: 16883013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.
    Gallamini A; Rigacci L; Merli F; Nassi L; Bosi A; Capodanno I; Luminari S; Vitolo U; Sancetta R; Iannitto E; Trentin L; Stelitano C; Tavera S; Biggi A; Castagnoli A; Versari A; Gregianin M; Pelosi E; Torchio P; Levis A
    Haematologica; 2006 Apr; 91(4):475-81. PubMed ID: 16585014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute varicella infection mimics recurrent Hodgkin's disease on F-18 FDG PET/CT.
    Sheehy N; Israel DA
    Clin Nucl Med; 2007 Oct; 32(10):820-1. PubMed ID: 17885370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
    Qiu L; Chen Y; Wu J
    Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
    Hutchings M; Loft A; Hansen M; Pedersen LM; Berthelsen AK; Keiding S; D'Amore F; Boesen AM; Roemer L; Specht L
    Haematologica; 2006 Apr; 91(4):482-9. PubMed ID: 16585015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
    Basu D; Siegel BA; McDonald DJ; Nussenbaum B
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy.
    Fagotti A; Fanfani F; Rossitto C; Lorusso D; De Gaetano AM; Giordano A; Vizzielli G; Scambia G
    Oncology; 2008; 75(3-4):152-8. PubMed ID: 18827492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer.
    Groheux D; Moretti JL; Baillet G; Espie M; Giacchetti S; Hindie E; Hennequin C; Vilcoq JR; Cuvier C; Toubert ME; Filmont JE; Sarandi F; Misset JL
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):695-704. PubMed ID: 18436392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-PET in the clinical management of Hodgkin lymphoma.
    Hutchings M; Eigtved AI; Specht L
    Crit Rev Oncol Hematol; 2004 Oct; 52(1):19-32. PubMed ID: 15363464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG-PET in the detection of residual disease and relapse in patients with Hodgkin's lymphoma. Experience from a Swedish centre.
    Bjurberg M; Gustavsson A; Ohlsson T; Brun E
    Acta Oncol; 2006; 45(6):743-9. PubMed ID: 16938818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
    Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
    Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fat necrosis mimicking B-cell lymphoma: a PET/CT and FDG study.
    Belakhlef A; Jani C; Church C; Fraser R; Lakhanpal S
    Clin Nucl Med; 2008 Apr; 33(4):271-2. PubMed ID: 18356666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
    Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE
    Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG-PET/CT findings in a patient with tuberculosis Hodgkin's disease and lupus vulgaris.
    Kaya E; Halac M; Sönmezoglu K; Sager S; Uslu I
    Hell J Nucl Med; 2009; 12(3):285-6. PubMed ID: 19936348
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonossifying fibroma can mimic residual lymphoma in FDG PET: additional value of combined PET/CT.
    von Falck C; Rosenthal H; Gratz KF; Galanski M
    Clin Nucl Med; 2007 Aug; 32(8):640-2. PubMed ID: 17667441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of PET-CT on involved field radiotherapy design for pediatric Hodgkin lymphoma.
    Paulino AC; Margolin J; Dreyer Z; Teh BS; Chiang S
    Pediatr Blood Cancer; 2012 Jun; 58(6):860-4. PubMed ID: 21826784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.